Pricing Log in Create free account

Moolec Science SA (MLEC) vs Virpax Pharmaceuticals, Inc. (VRPX)

Moolec Science SA and Virpax Pharmaceuticals, Inc. are both Biotechnology companies. Moolec Science SA is the larger, with a market value of $620.0K against $160.0K — 3.9× the size. Virpax Pharmaceuticals, Inc. has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Virpax Pharmaceuticals, Inc. leads on 6 and Moolec Science SA on 5.

Valuation

Metric MLEC VRPX Biotechnology median
P/E n/m n/m 10.60
P/S 0.03 n/m 9.40
P/B 0.01 n/m 2.13
Price to free cash flow 0.01 n/m 25.18
EV/EBITDA 1.76 0.04 0.66
EV/Sales 8.37 n/m 9.02
Earnings yield (3,822.12%) 0.00% (32.88%)
Free cash flow yield 8,301.70% 0.00% (23.13%)

Profitability

Metric MLEC VRPX Biotechnology median
Gross margin 2,373.25% — 68.51%
Operating margin 244.93% 0.00% 0.00%
Net margin (105.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (2,364.98%) (51.96%)
Return on assets 0.00% (215.80%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MLEC VRPX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (793.17%) 78.10% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLEC VRPX Biotechnology median
Debt to equity 4.37 0.00 0.00
Current ratio 0.15 0.63 4.97
Net debt to EBITDA (2.73) 0.13 1.01

Dividend

Metric MLEC VRPX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MLEC VRPX Biotechnology median
Market cap 620.00k 160.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack